Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Telford

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Blood|July 29, 2008
Exogenous insulin-like growth factor 1 enhances thymopoiesis predominantly through thymic epithelial cell expansionYu-Waye Chu, Sabrina Schmitz, Baishakhi Choudhury, et al.
BMC Cancer|June 24, 2008
Rapamycin delays growth of Wnt-1 tumors in spite of suppression of host immunityElena V Svirshchevskaya, Jacopo Mariotti, Mollie H Wright, et al.
Histochemistry and Cell Biology|January 18, 2007
Clustered carbohydrates as a target for natural killer cells: a model systemElena I Kovalenko, Elena Abakushina, William Telford, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2007
Ex vivo rapamycin generates apoptosis-resistant donor Th2 cells that persist in vivo and prevent hemopoietic stem cell graft rejectionJacopo Mariotti, Jason Foley, Unsu Jung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2016
Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host DiseaseFrances T Hakim, Sarfraz Memon, Ping Jin, et al.
Blood Advances|December 22, 2020
Intrabone transplantation of CD34+ cells with optimized delivery does not enhance engraftment in a rhesus macaque modelKate Stringaris, Robert F Hoyt, Jan K Davidson-Moncada, et al.
Immunity|March 15, 2025
Anti-vascular endothelial growth factor treatment potentiates immune checkpoint blockade through a BAFF- and IL-12-dependent reprogramming of the TMEMohamed-Reda Benmebarek, Cihan Oguz, Matthias Seifert, et al.
Gut|August 3, 2021
The tumour microenvironment shapes innate lymphoid cells in patients with hepatocellular carcinomaBernd Heinrich, E Michael Gertz, Alejandro A Schäffer, et al.
Nature Communications|April 23, 2026
Allogeneic hematopoietic cell transplantation in mature T- or NK-lymphomas: a phase II clinical trialKamil A Rechache, Natalia S Nunes, Jennifer Sponaugle, et al.
The Journal of Allergy and Clinical Immunology|March 1, 2026
Allogeneic hematopoietic cell transplantation for partial RAG deficiency in children and adults: excellent outcomes with a reduced intensity, posttransplantation cyclophosphamide-based approachDimana Dimitrova, Marita Bosticardo, Ottavia M Delmonte, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Blood|July 29, 2008
Exogenous insulin-like growth factor 1 enhances thymopoiesis predominantly through thymic epithelial cell expansionYu-Waye Chu, Sabrina Schmitz, Baishakhi Choudhury, et al.
BMC Cancer|June 24, 2008
Rapamycin delays growth of Wnt-1 tumors in spite of suppression of host immunityElena V Svirshchevskaya, Jacopo Mariotti, Mollie H Wright, et al.
Histochemistry and Cell Biology|January 18, 2007
Clustered carbohydrates as a target for natural killer cells: a model systemElena I Kovalenko, Elena Abakushina, William Telford, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2007
Ex vivo rapamycin generates apoptosis-resistant donor Th2 cells that persist in vivo and prevent hemopoietic stem cell graft rejectionJacopo Mariotti, Jason Foley, Unsu Jung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2016
Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host DiseaseFrances T Hakim, Sarfraz Memon, Ping Jin, et al.
Blood Advances|December 22, 2020
Intrabone transplantation of CD34+ cells with optimized delivery does not enhance engraftment in a rhesus macaque modelKate Stringaris, Robert F Hoyt, Jan K Davidson-Moncada, et al.
Immunity|March 15, 2025
Anti-vascular endothelial growth factor treatment potentiates immune checkpoint blockade through a BAFF- and IL-12-dependent reprogramming of the TMEMohamed-Reda Benmebarek, Cihan Oguz, Matthias Seifert, et al.
Gut|August 3, 2021
The tumour microenvironment shapes innate lymphoid cells in patients with hepatocellular carcinomaBernd Heinrich, E Michael Gertz, Alejandro A Schäffer, et al.
Nature Communications|April 23, 2026
Allogeneic hematopoietic cell transplantation in mature T- or NK-lymphomas: a phase II clinical trialKamil A Rechache, Natalia S Nunes, Jennifer Sponaugle, et al.
The Journal of Allergy and Clinical Immunology|March 1, 2026
Allogeneic hematopoietic cell transplantation for partial RAG deficiency in children and adults: excellent outcomes with a reduced intensity, posttransplantation cyclophosphamide-based approachDimana Dimitrova, Marita Bosticardo, Ottavia M Delmonte, et al.
Pageof 3